• About Us
    • About MS Australia
    • Our People
    • Partnerships
    • Reports and Financials
  • For People with MS
    • What is MS?
      • MS Symptoms
      • How is MS diagnosed?
      • Types of MS
      • MS Treatments
    • NMOSD and MOGAD
    • Health and Wellbeing
    • MS Nurses
    • MS Clinics
    • Employment
    • Participate in MS Research
    • Popular topics
    • For family, friends and other carers
    • Support and Services
    • Crisis Toolkit
    • COVID-19 and MS
  • FOR RESEARCHERS
    • Funding Opportunities
    • Online Grant Portal
    • MS Research Resource Portal
    • Grant Documents and Templates
    • Research We Fund
  • Research
    • Research We Fund
    • Research Strategy and Governance
    • National Collaborations
      • AHSCT
      • ANZgene
      • Ausimmune Study
      • Australian MS Longitudinal Study
      • EBV in MS
      • InforMS
      • MS Brain Bank
      • MS Clinical Trials
      • Proteomics of MS
      • PLATYPUS
      • Vitamin D MS Prevention Trial – PrevANZ
    • Global Collaborations
      • International Progressive MS Alliance
      • MS International Federation (MSIF)
      • The International MS Genetics Consortium
      • MS Brain Health
      • Kiss Goodbye to MS
    • Participate in MS Research
    • MS Glossary
  • Advocacy
    • Federal Election 2025
    • Alliances
    • Carer Strategy
    • Consumer Engagement Roadmap
    • Lived Experience Expert Panel
    • MS Nurses
    • NDIS
    • Parliamentary Friends of MS
    • Submissions
  • Get Involved
    • MS Australia Awards
    • World MS Day 2024
    • Ways to Donate
      • Donate
      • Leave a Gift in your Will
      • Workplace Giving
      • Give in Memory
      • Celebration donation
      • Your Contribution
      • Fundraise with The May 50K
      • Fundraise with Kiss Goodbye to MS
    • Participate in MS research
    • Events
    • Lived Experience Expert Panel
    • Corporate involvement
    • Volunteers
Menu
  • About Us
    • About MS Australia
    • Our People
    • Partnerships
    • Reports and Financials
  • For People with MS
    • What is MS?
      • MS Symptoms
      • How is MS diagnosed?
      • Types of MS
      • MS Treatments
    • NMOSD and MOGAD
    • Health and Wellbeing
    • MS Nurses
    • MS Clinics
    • Employment
    • Participate in MS Research
    • Popular topics
    • For family, friends and other carers
    • Support and Services
    • Crisis Toolkit
    • COVID-19 and MS
  • FOR RESEARCHERS
    • Funding Opportunities
    • Online Grant Portal
    • MS Research Resource Portal
    • Grant Documents and Templates
    • Research We Fund
  • Research
    • Research We Fund
    • Research Strategy and Governance
    • National Collaborations
      • AHSCT
      • ANZgene
      • Ausimmune Study
      • Australian MS Longitudinal Study
      • EBV in MS
      • InforMS
      • MS Brain Bank
      • MS Clinical Trials
      • Proteomics of MS
      • PLATYPUS
      • Vitamin D MS Prevention Trial – PrevANZ
    • Global Collaborations
      • International Progressive MS Alliance
      • MS International Federation (MSIF)
      • The International MS Genetics Consortium
      • MS Brain Health
      • Kiss Goodbye to MS
    • Participate in MS Research
    • MS Glossary
  • Advocacy
    • Federal Election 2025
    • Alliances
    • Carer Strategy
    • Consumer Engagement Roadmap
    • Lived Experience Expert Panel
    • MS Nurses
    • NDIS
    • Parliamentary Friends of MS
    • Submissions
  • Get Involved
    • MS Australia Awards
    • World MS Day 2024
    • Ways to Donate
      • Donate
      • Leave a Gift in your Will
      • Workplace Giving
      • Give in Memory
      • Celebration donation
      • Your Contribution
      • Fundraise with The May 50K
      • Fundraise with Kiss Goodbye to MS
    • Participate in MS research
    • Events
    • Lived Experience Expert Panel
    • Corporate involvement
    • Volunteers
NEWS
RESOURCES
PODCAST
  • NEWS
  • RESOURCES
  • PODCAST
  • VIDEOS
  • CONTACT
Donate
Subscribe
Search
  • About Us
    • About MS Australia
    • Our People
    • Partnerships
    • Reports and Financials
  • For People with MS
    • What is MS?
      • MS Symptoms
      • How is MS diagnosed?
      • Types of MS
      • MS Treatments
    • NMOSD and MOGAD
    • Health and Wellbeing
    • MS Nurses
    • MS Clinics
    • Employment
    • Participate in MS Research
    • Popular topics
    • For family, friends and other carers
    • Support and Services
    • Crisis Toolkit
    • COVID-19 and MS
  • FOR RESEARCHERS
    • Funding Opportunities
    • Online Grant Portal
    • MS Research Resource Portal
    • Grant Documents and Templates
    • Research We Fund
  • Research
    • Research We Fund
    • Research Strategy and Governance
    • National Collaborations
      • AHSCT
      • ANZgene
      • Ausimmune Study
      • Australian MS Longitudinal Study
      • EBV in MS
      • InforMS
      • MS Brain Bank
      • MS Clinical Trials
      • Proteomics of MS
      • PLATYPUS
      • Vitamin D MS Prevention Trial – PrevANZ
    • Global Collaborations
      • International Progressive MS Alliance
      • MS International Federation (MSIF)
      • The International MS Genetics Consortium
      • MS Brain Health
      • Kiss Goodbye to MS
    • Participate in MS Research
    • MS Glossary
  • Advocacy
    • Federal Election 2025
    • Alliances
    • Carer Strategy
    • Consumer Engagement Roadmap
    • Lived Experience Expert Panel
    • MS Nurses
    • NDIS
    • Parliamentary Friends of MS
    • Submissions
  • Get Involved
    • MS Australia Awards
    • World MS Day 2024
    • Ways to Donate
      • Donate
      • Leave a Gift in your Will
      • Workplace Giving
      • Give in Memory
      • Celebration donation
      • Your Contribution
      • Fundraise with The May 50K
      • Fundraise with Kiss Goodbye to MS
    • Participate in MS research
    • Events
    • Lived Experience Expert Panel
    • Corporate involvement
    • Volunteers
Menu
  • About Us
    • About MS Australia
    • Our People
    • Partnerships
    • Reports and Financials
  • For People with MS
    • What is MS?
      • MS Symptoms
      • How is MS diagnosed?
      • Types of MS
      • MS Treatments
    • NMOSD and MOGAD
    • Health and Wellbeing
    • MS Nurses
    • MS Clinics
    • Employment
    • Participate in MS Research
    • Popular topics
    • For family, friends and other carers
    • Support and Services
    • Crisis Toolkit
    • COVID-19 and MS
  • FOR RESEARCHERS
    • Funding Opportunities
    • Online Grant Portal
    • MS Research Resource Portal
    • Grant Documents and Templates
    • Research We Fund
  • Research
    • Research We Fund
    • Research Strategy and Governance
    • National Collaborations
      • AHSCT
      • ANZgene
      • Ausimmune Study
      • Australian MS Longitudinal Study
      • EBV in MS
      • InforMS
      • MS Brain Bank
      • MS Clinical Trials
      • Proteomics of MS
      • PLATYPUS
      • Vitamin D MS Prevention Trial – PrevANZ
    • Global Collaborations
      • International Progressive MS Alliance
      • MS International Federation (MSIF)
      • The International MS Genetics Consortium
      • MS Brain Health
      • Kiss Goodbye to MS
    • Participate in MS Research
    • MS Glossary
  • Advocacy
    • Federal Election 2025
    • Alliances
    • Carer Strategy
    • Consumer Engagement Roadmap
    • Lived Experience Expert Panel
    • MS Nurses
    • NDIS
    • Parliamentary Friends of MS
    • Submissions
  • Get Involved
    • MS Australia Awards
    • World MS Day 2024
    • Ways to Donate
      • Donate
      • Leave a Gift in your Will
      • Workplace Giving
      • Give in Memory
      • Celebration donation
      • Your Contribution
      • Fundraise with The May 50K
      • Fundraise with Kiss Goodbye to MS
    • Participate in MS research
    • Events
    • Lived Experience Expert Panel
    • Corporate involvement
    • Volunteers
First ever treatment approved for secondary progressive MS 13 November 2019
MS Brainbank MS News MS Trials
First ever treatment approved for secondary progressive MS
New genetic map shows different immune cells involved in MS onset 15 October 2019
MS Brainbank MS News MS Trials
New genetic map shows different immune cells involved in MS onset
New test to help with diagnosis of demyelinating conditions 14 October 2019
MS Brainbank MS News MS Trials
New test to help with diagnosis of demyelinating conditions
What determines conversion to secondary progressive MS? 21 September 2019
MS Brainbank MS News MS Trials
What determines conversion to secondary progressive MS?
Siponimod under consideration for treatment of secondary progressive MS 4 September 2019
MS Brainbank MS News MS Trials
Siponimod under consideration for treatment of secondary progressive MS
Younger people with MS to benefit from PBAC recommendations 26 August 2019
MS Brainbank MS News MS Trials
Younger people with MS to benefit from PBAC recommendations
Changes in brain activity in people with CIS 20 August 2019
MS Brainbank MS News MS Trials
Changes in brain activity in people with CIS
Quick test could help detect changes in thinking and memory 20 August 2019
MS Brainbank MS News MS Trials
Quick test could help detect changes in thinking and memory
Remyelination therapies on trial 20 August 2019
MS Brainbank MS News MS Trials
Remyelination therapies on trial
Diet during adolescence linked to MS risk 19 August 2019
MS Brainbank MS News MS Trials
Diet during adolescence linked to MS risk
Load More
MS Australia
registered charity

1300 010 158

info@msaustralia.org.au

Head Office

Suite 3.01, 18 Flour Mill Way
Summer Hill NSW 2130

Participate in MS Research

  • MS Clinical Trials
  • MS Australia Brain Bank
  • Australian MS Longitudinal Study
Facebook-f X-twitter Linkedin-in Youtube Spotify Paper-plane

Quick links

  • What is MS?
  • How is MS diagnosed?
  • COVID-19 and MS
  • Research funding opportunities
  • Research we fund
  • Media enquiries
  • Contact us
© 2025 Multiple Sclerosis Australia | ABN: 51 008 515 508 │Privacy Policy | Whistleblower Policy | Complaints Policy | Terms and Conditions
© 2024 Multiple Sclerosis Australia
ABN: 51 008 515 508
Privacy Policy | Whistleblower Policy
Complaints Policy | Terms and Conditions
SUBSCRIBE
DONATE
CONTACT

Newsletter subscription

  • Enter your details

First ever treatment approved for secondary progressive MS